uniQure N.V. Other Nonoperating Income
uniQure N.V. (QURE) reported Other Nonoperating Income of $2.76 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-28.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2024-02-28
- uniQure N.V. other nonoperating income for fiscal 2022 was $2.76M.
- uniQure N.V. other nonoperating income for fiscal 2020 was $483.00K.
- uniQure N.V. other nonoperating income for fiscal 2018 was $208.00K.
- uniQure N.V. other nonoperating income for fiscal 2016 was $785.00K, a 85.58% increase from fiscal 2015.
| Period end | Other Nonoperating Income 12 month |
|---|---|
| 2022-12-31 | $2.76M 10-K · filed 2024-02-28 |
| 2020-12-31 | $483.00K 10-K · filed 2023-02-27 |
| 2018-12-31 | $208.00K 10-K · filed 2021-03-01 |
| 2016-12-31 | $785.00K 10-K · filed 2019-02-28 |
| 2015-12-31 | $423.00K 10-K · filed 2018-03-14 |
| 2014-12-31 | $21.00K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |